Yong Chen Selected Research

Immunotherapy

1/2022	FTO in cancer: functions, molecular mechanisms, and therapeutic implications.
1/2022	The Combination of Radiation Therapy and Immunotherapy Is Effective and Well-Tolerated for Unresectable Biliary Tract Cancer.
12/2021	The role of B7-H3 in tumors and its potential in clinical application.
12/2021	IL-27 signalling promotes adipocyte thermogenesis and energy expenditure.
10/2021	Melanoma Differentiation Trajectories Determine Sensitivity toward Pre-Existing CD8+ Tumor-Infiltrating Lymphocytes.
10/2021	Research Progress and Challenges in the Treatment of Central Nervous System Metastasis of Non-Small Cell Lung Cancer.
1/2021	Anticancer Effects and Mechanisms of OSW-1 Isolated From Ornithogalum saundersiae: A Review.
10/2020	Engineering Strategies for Lymph Node Targeted Immune Activation.
6/2018	TP53 Mutation as Potential Negative Predictor for Response of Anti-CTLA-4 Therapy in Metastatic Melanoma.
2/2015	Kimura's disease or IgG4-related disease? A case-based review.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yong Chen Research Topics

Disease

255	Neoplasms (Cancer) 07/2022 - 06/2002
65	Inflammation (Inflammations) 12/2022 - 06/2002
50	Neoplasm Metastasis (Metastasis) 03/2022 - 10/2005
43	Pain (Aches) 01/2022 - 05/2002
38	Hepatocellular Carcinoma (Hepatoma) 07/2022 - 06/2002
38	Infections 02/2022 - 08/2003
33	Nasopharyngeal Carcinoma 03/2022 - 10/2005
32	Glioma (Gliomas) 01/2022 - 01/2013
28	Carcinoma (Carcinomatosis) 11/2021 - 11/2002
21	Lung Neoplasms (Lung Cancer) 05/2022 - 12/2005
20	Atherosclerosis 07/2022 - 02/2008
20	Insulin Resistance 01/2022 - 08/2003
19	Breast Neoplasms (Breast Cancer) 10/2022 - 02/2003
18	Fibrosis (Cirrhosis) 12/2022 - 04/2003
18	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 07/2013
17	Hypoxia (Hypoxemia) 05/2022 - 01/2008
16	Stomach Neoplasms (Stomach Cancer) 05/2022 - 10/2007
16	Melanoma (Melanoma, Malignant) 01/2022 - 01/2012
16	Osteosarcoma (Osteogenic Sarcoma) 09/2021 - 05/2012
15	Liver Neoplasms (Liver Cancer) 01/2022 - 08/2003
15	Hemorrhage 06/2021 - 07/2003
14	Necrosis 05/2022 - 10/2003
14	Reperfusion Injury 02/2022 - 01/2008
13	Lymphatic Metastasis 01/2022 - 09/2006
13	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2010
13	Stroke (Strokes) 01/2022 - 12/2002
12	COVID-19 11/2022 - 01/2020
12	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2021 - 11/2002
12	Hyperalgesia 01/2021 - 11/2003
11	Carcinogenesis 07/2022 - 03/2003
11	Thrombosis (Thrombus) 01/2022 - 02/2014
11	Rheumatoid Arthritis 01/2021 - 04/2008
10	Sepsis (Septicemia) 10/2022 - 04/2003
10	Wounds and Injuries (Trauma) 02/2022 - 07/2003
10	Experimental Arthritis 01/2022 - 01/2016
10	Ischemic Stroke 01/2022 - 12/2002
10	Liver Diseases (Liver Disease) 01/2022 - 04/2003
10	Hypertension (High Blood Pressure) 01/2022 - 05/2010
10	Parkinson Disease (Parkinson's Disease) 01/2022 - 01/2016
10	Disease Progression 01/2021 - 06/2002
10	Brain Injuries (Brain Injury) 01/2019 - 12/2002
9	Body Weight (Weight, Body) 02/2022 - 06/2014
9	Obesity 12/2021 - 01/2016
9	Human Influenza (Influenza) 01/2021 - 05/2009
9	Chronic Hepatitis B 01/2021 - 05/2007
8	Osteoarthritis 03/2022 - 11/2014
8	Heart Failure 01/2022 - 03/2009
8	Infarction (Infarctions) 01/2022 - 12/2003

Drug/Important Bio-Agent (IBA)

95	Proteins (Proteins, Gene)FDA Link 05/2022 - 06/2002
61	Biomarkers (Surrogate Marker)IBA 12/2022 - 03/2009
54	Pharmaceutical PreparationsIBA 07/2022 - 06/2002
37	Messenger RNA (mRNA)IBA 03/2022 - 04/2005
35	CytokinesIBA 07/2022 - 06/2003
32	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2008
31	DNA (Deoxyribonucleic Acid)IBA 03/2022 - 05/2007
26	Glucose (Dextrose)FDA LinkGeneric 05/2022 - 08/2003
25	Therapeutic UsesIBA 07/2022 - 09/2004
24	LipidsIBA 01/2022 - 02/2008
21	Biological ProductsIBA 01/2022 - 11/2005
20	Long Noncoding RNAIBA 07/2022 - 04/2017
17	RNA (Ribonucleic Acid)IBA 01/2022 - 03/2003
15	Temozolomide (Temodar)FDA LinkGeneric 01/2022 - 10/2015
14	Small Interfering RNA (siRNA)IBA 01/2022 - 01/2008
14	VaccinesIBA 01/2022 - 08/2003
13	Indicators and Reagents (Reagents)IBA 12/2022 - 04/2011
13	Anti-Bacterial Agents (Antibiotics)IBA 02/2022 - 06/2005
13	C-Reactive ProteinIBA 06/2021 - 03/2007
12	Antiviral Agents (Antivirals)IBA 04/2021 - 05/2007
12	Freund's AdjuvantIBA 11/2018 - 11/2003
11	Cisplatin (Platino)FDA LinkGeneric 07/2022 - 12/2010
11	Peptides (Polypeptides)IBA 05/2022 - 08/2012
11	EnzymesIBA 01/2022 - 03/2010
10	Interleukin-6 (Interleukin 6)IBA 07/2022 - 04/2012
10	AntigensIBA 01/2022 - 08/2003
10	CholesterolIBA 07/2021 - 02/2008
9	Analgesics (Analgesic Drugs)IBA 11/2022 - 05/2008
9	oxidized low density lipoproteinIBA 07/2022 - 03/2013
9	Transcription Factors (Transcription Factor)IBA 05/2022 - 04/2008
9	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2022 - 07/2013
9	Phosphotransferases (Kinase)IBA 01/2022 - 08/2010
9	Triglycerides (Triacylglycerol)IBA 01/2022 - 08/2011
9	CyclodextrinsIBA 03/2021 - 04/2012
8	MethyltransferasesIBA 06/2022 - 01/2013
8	LigandsIBA 03/2022 - 01/2013
8	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 02/2003
8	Protein Isoforms (Isoforms)IBA 01/2022 - 10/2007
8	AlbuminsIBA 08/2021 - 01/2014
8	Insulin (Novolin)FDA Link 08/2021 - 08/2003

Therapy/Procedure

118	Therapeutics 03/2022 - 06/2002
51	Drug Therapy (Chemotherapy) 07/2022 - 08/2008
37	Radiotherapy 06/2022 - 10/2005
16	Transplantation 05/2021 - 09/2003
15	Lymph Node Excision (Lymph Node Dissection) 11/2020 - 11/2002
12	Hysterectomy 01/2021 - 11/2002
10	Length of Stay 10/2022 - 03/2013
10	Neoadjuvant Therapy 02/2022 - 05/2012
10	Chinese Traditional Medicine (Traditional Chinese Medicine) 02/2022 - 05/2015
10	Immunotherapy 01/2022 - 02/2015
9	Chemoradiotherapy 05/2022 - 08/2008
8	Aftercare (After-Treatment) 11/2022 - 04/2008